Vincerx Pharma
$17.609876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$17.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.70 (-3.83%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Vincerx Pharma and other stocks, options, and ETFs commission-free!
About VINC
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.
CEO
Ahmed Hamdy
Employees
28
Headquarters
Palo Alto, California
Founded
2018
Market Cap
240.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
61.28K
High Today
$18.50
Low Today
$17.50
Open Price
$18.50
Volume
68.24K
52 Week High
$26.75
52 Week Low
$9.35
VINC Earnings
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 15, Pre-Market